OmniLife

OmniLife Health provides a clinical workflow automation platform focused on complex care environments, with a primary specialization in organ transplantation. The company's business model is software-as-a-service (SaaS), offering its products to hospitals and health systems with pricing based on the specific service lines a client uses. Notable clients include Mayo Clinic, Cedars Sinai, and UPMC.

The company was founded in 2016 as HealthTech Solutions by Dalton Shaull and Eric Pahl, who met at an entrepreneurial event at the University of Iowa. The inspiration for the company was deeply personal. Shaull, the CEO, experienced a near-fatal motorcycle accident that led to a nerve transplant to regain function in his arm. This experience, combined with a co-founder's family history with liver failure and a transplant surgeon uncle, sparked the mission to improve the complex organ transplant process. Both founders were recognized on the Forbes '30 Under 30' list in 2018 for their work. In October 2024, OmniLife Health was acquired by XVIVO.

OmniLife Health's core product is the FlowHawk™ platform, designed to connect and facilitate collaboration among care teams, digitizing critical communications that often happen outside of the Electronic Health Record (EHR). Initially launched as a secure messaging tool, TXP Chat, in 2018, the platform has evolved into a comprehensive solution that automates and standardizes workflows. It addresses processes like organ intake management, patient waitlist management, living donor coordination, and post-transplant care. The platform has demonstrated significant impact, including a 50% reduction in time from organ offer to transplant and a 35% increase in organs transplanted at facilities using the technology. Beyond transplantation, the company is expanding its platform to other complex areas such as oncology (bone marrow and prostate cancer), cardiology, and organ failure care for nephrology, pulmonology, and hepatology.

Financially, the company has been supported by angel investors and has successfully secured non-dilutive funding through substantial grants from the National Institutes of Health (NIH), including a Small Business Innovation Research (SBIR) grant. These funds have supported research to enhance organ utilization, such as a study to increase organ donation acceptance and a project using AI to optimize graft selection for pediatric liver transplants. Keywords: clinical workflow automation, organ transplant software, care collaboration platform, healthcare communication, FlowHawk, patient intake management, organ failure care, complex care coordination, health systems software, transplant logistics, living donor coordination, procurement billing, HIPAA-compliant messaging, clinical decision support, pediatric transplant, Dalton Shaull, Eric Pahl, HealthTech Solutions, medical workflow software, care team collaboration